Regional Medicare administrators CGS, NGS, Noridian, Palmetto, and WPS today proposed new coverage policies for medical Botox injections, including injections for treatment of blepharospasm, strabismus, and hemifacial spasm. We are deeply concerned about the proposal to put impractical dosing guidelines on treating blepharospasm with Botox. The Academy is working with ASOPRS and NANOS to ensure patient access to medically necessary treatments.
Member exclusive - Locked
Log in to keep reading.
Join AAO to get unlimited access to content. See member benefits or join today.